Ropinirole (both immediate- and extended-release tablets) may be used for the treatment of Parkinson's Disease
This results in an overwhelming feeling of Mechanism of Action: REQUIP is a non-ergoline dopamine agonist with high relative in vitro specificity and full intrinsic activity at the D 2 and D 3 dopamine receptor subtypes, binding with higher affinity to D 3 than to D 2 or D 4 receptor subtypes